VALENTINE Nivedita

As Vice President of Global Product Innovation, Nivedita oversees heads Pharmanovia’s pipeline strategy, with a primary focus on novel therapeutic options in neurology, cardiology, endocrinology & oncology supportive care, as well as the revitalization of legacy iconic brands.

Some of her other associations include

• IRDiRC (International Rare Diseases Research Consortium) task force for funding models for rare diseases and Drug Repurposing Guidebook, which aims to improve care for people with rare diseases.
• Remedi4all is a funders network led by ZonMw and in collaboration with the Anticancer Fund dedicated to advancing Drug Repurposing initiatives.
• Medicines for Europe’s Value-Added Medicines (VAM) Sector Leadership Group, which aims to rethink, reinvent and optimise medicines based on known molecules by bringing untapped innovation to improve care delivery. Additionally, the group provides industry insights into evolving EU pharmaceutical legislation regarding repurposed medicines.

Before Pharmanovia, Nivedita held various senior management positions, responsible for leading portfolio planning and business development covering international markets.

She has a Masters in Biochemistry and a Master’s in Business Administration.